Evaxion Biotech A/SNASDAQ:EVAXNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.6800
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.6583/ 1
- Ask / Lots0.7000/ 49
- Open / Previous Close0.0000 / 0.6800
- Day Range---
- 52 Week Range
- Volume51
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | EVAX |
|---|---|---|
| 09:32 ET | 14991 | 0.64 |
| 09:33 ET | 2710 | 0.634999 |
| 09:35 ET | 184 | 0.62 |
| 09:37 ET | 4250 | 0.64 |
| 09:39 ET | 400 | 0.64 |
| 09:44 ET | 2300 | 0.630001 |
| 09:46 ET | 906 | 0.62 |
| 09:48 ET | 1200 | 0.6298 |
| 09:51 ET | 2280 | 0.63 |
| 09:53 ET | 120 | 0.63 |
| 09:57 ET | 300 | 0.63 |
| 10:04 ET | 2004 | 0.65 |
| 10:06 ET | 1442 | 0.6392 |
| 10:08 ET | 1100 | 0.65 |
| 10:09 ET | 339 | 0.655 |
| 10:15 ET | 17310 | 0.66 |
| 10:20 ET | 100 | 0.65 |
| 10:22 ET | 2300 | 0.6401 |
| 10:24 ET | 350 | 0.655 |
| 10:26 ET | 1197 | 0.654 |
| 10:33 ET | 716 | 0.6401 |
| 10:40 ET | 200 | 0.644 |
| 10:42 ET | 550 | 0.64 |
| 10:44 ET | 1056 | 0.6699 |
| 10:45 ET | 1000 | 0.6695 |
| 11:00 ET | 5143 | 0.659501 |
| 11:02 ET | 700 | 0.6401 |
| 11:34 ET | 4897 | 0.665 |
| 11:36 ET | 3168 | 0.6647 |
| 11:48 ET | 200 | 0.6799 |
| 11:54 ET | 592 | 0.679699 |
| 11:56 ET | 100 | 0.6798 |
| 11:57 ET | 300 | 0.6501 |
| 12:08 ET | 1600 | 0.6749 |
| 12:10 ET | 2400 | 0.67 |
| 12:17 ET | 5200 | 0.666539 |
| 12:19 ET | 111 | 0.669899 |
| 12:24 ET | 250 | 0.6699 |
| 12:46 ET | 100 | 0.6699 |
| 12:53 ET | 2000 | 0.6601 |
| 01:04 ET | 250 | 0.660101 |
| 01:13 ET | 2118 | 0.6699 |
| 01:15 ET | 100 | 0.67 |
| 01:27 ET | 811 | 0.666351 |
| 01:56 ET | 250 | 0.660101 |
| 02:09 ET | 105 | 0.6699 |
| 02:30 ET | 746 | 0.6698 |
| 02:34 ET | 1497 | 0.6699 |
| 02:50 ET | 100 | 0.6699 |
| 02:52 ET | 240 | 0.67 |
| 03:08 ET | 300 | 0.665499 |
| 03:10 ET | 700 | 0.67 |
| 03:44 ET | 1000 | 0.68 |
| 03:50 ET | 300 | 0.66 |
| 03:55 ET | 134 | 0.68 |
| 04:00 ET | 749 | 0.68 |
Nov 28, 2023
Evaxion to Unveil Potentially Groundbreaking AI-Immunology(TM) Precision Cancer Vaccine Concept, from 8:27AM ET on Tuesday Nov 28, 2023 by Dow Jones
8:27AM ET on Tuesday Nov 28, 2023 by Dow Jones
Nov 15, 2023
Evaxion Presents Proof-of-Principle for Its Unique AI Model Predicting Responses to Cancer Immunotherapy, from 8:00AM ET on Wednesday Nov 15, 2023 by Dow Jones
8:00AM ET on Wednesday Nov 15, 2023 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Evaxion Biotech A/S | 18.8M | -0.7x | --- |
Forte Biosciences Inc | 18.6M | -0.4x | --- |
Aptose Biosciences Inc | 19.2M | -0.3x | --- |
Viracta Therapeutics Inc | 19.1M | -0.4x | --- |
CalciMedica Inc | 19.3M | -0.1x | --- |
Indaptus Therapeutics Inc | 18.3M | -1.2x | --- |
Company Information
Evaxion Biotech A/S is a Denmark-based clinical-stage biotechnology company, which specializes in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases. The Company decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.
Contact Information
- Headquarters
- Bredgade 34E, Copenhagen KCOPENHAGEN, Denmark 1260
- Phone
- ---
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $18.8M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 27.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.98 |
Book Value | $0.34 |
P/E Ratio | -0.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
